Z6尊龙
Other Affiliated Sites
Techdow Pharma China
Techdow Pharma UK
Techdow Pharma Poland
Techdow Pharma Italy
Techdow Pharma Spain
Techdow Pharma Germany
Techdow Pharma US
Cytovance Biologics
SPL
Simplified Chinese
Traditional Chinese
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Business
Global Industrial Chain
Global Heparin Injections Business
Product Profile
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Job Opportunities
Campus Recruitment
Contact Us
Create Value for Investors Through
Safe and Stable Operations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Corporate Governance
2010.06.19
公司章程(2010年6月)
2010.06.19
避免大股东占用上市公司资金治理步伐(2010年6月)
2010.06.19
自力董事关于2010年度预计一样平常谋划性关联生意事项的意见函
2010.06.19
自力董事关于任免公司高级治理职员的自力意见
2010.06.19
突发事务治理制度(2010年6月)
2010.05.19
敏感信息排查治理制度(2010年5月)
2010.05.19
自力董事年报事情制度(2010年5月)
2010.05.19
董事会审计委员会年度财务报告事情制度(2010年5月)
2010.05.19
对外担保治理制度(2010年5月)
2010.05.19
内部审计治理制度(2010年5月)
第一页
上一页
21
22
23
24
25
下一页
最后一页
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Business
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Job Opportunities
Campus Recruitment
Contact Us
Official WeChat Account
Legal Statement
·
Environmental Disclosure
Copyright ? 2024 Hepalink Group. All Rights Reserved.
【网站地图】
【sitemap】